SCHEMBL5042589

SCHEMBL5042589

CCOC(C(=O)O)c1ccc(OC)c(O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.48
TSHR P16473 2/20 0.47
BLM P54132 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
TUBB4A P04350 3/20 0.46
TUBB P07437 3/20 0.46
TUBA3C P0DPH7 3/20 0.46
TUBA1B P68363 3/20 0.46
TUBA4A P68366 3/20 0.46
TUBB4B P68371 3/20 0.46
TUBB3 Q13509 3/20 0.46
TUBB2A Q13885 3/20 0.46
TUBB8 Q3ZCM7 3/20 0.46
TUBA3E Q6PEY2 3/20 0.46
TUBA1A Q71U36 3/20 0.46
TUBA1C Q9BQE3 3/20 0.46
TUBB6 Q9BUF5 3/20 0.46
TUBB2B Q9BVA1 3/20 0.46
TUBB1 Q9H4B7 3/20 0.46
CYP19A1 P11511 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5037707 0.84 NPSR1 (0.51) GAATSHRBLMNPSR1TUBB4A
SCHEMBL8461912 0.81 NPSR1 (0.48) GAATSHRBLMNPSR1TUBB4A
SCHEMBL5377880 0.80 TUBB1 (0.51) GAATSHRNPSR1TUBB4ATUBB
SCHEMBL5047655 0.78 SMPD1 (0.53) GAANPSR1POLBPDE4APDE4B
SCHEMBL24328885 0.76 HPGD (0.51) TSHRPOLBLDHA
SCHEMBL352960 0.76 NPSR1 (0.76) GAATSHRBLMNPSR1TUBB4A
SCHEMBL10085812 0.76 NPSR1 (0.76) GAATSHRBLMNPSR1TUBB4A
SCHEMBL490724 0.76 AKR1C3 (0.57) GAATSHRBLMNPSR1TUBB4A
SCHEMBL503700 0.76 NPSR1 (0.76) GAATSHRBLMNPSR1TUBB4A
SCHEMBL10355170 0.76 ESR1 (0.44) NPSR1ALOX15ACHECYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567498-B1 MANDELIC ACID DERIVATIVES HOFFMANN LA ROCHE (CH) 2008-01-23 EP disclosed
US-7129238-B2 Mandelic acid derivatives HOFFMANN-LA ROCHE INC. (US) 2006-10-31 US disclosed
EP-1567498-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2005-08-31 EP disclosed
US-20040122057-A1 Novel mandelic acid derivatives HOFFMANN-LA ROCHE INC. 2004-06-24 US disclosed
WO-2004048335-A2 MANDELIC ACID DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040122057-A1 Novel mandelic acid derivatives F7, F11, F9 GAA 1312/4885TSHR 2403/4885BLM 3909/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.